CoChat

ADAR RNA Modifications, the Epitranscriptome and Innate Immunity

Quin, Jaclyn, Sedmík, Jiří, Vukić, Dragana, Khan, Anzer, Keegan, Liam P., O’Connell, Mary A. · 2021 · Trends in Biochemical Sciences
Cited by 148

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tibs.2021.02.002

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 86

  1. Boccaletto, 2018, MODOMICS: a database of RNA modification pathways. 2017 update, Nucleic Acids Res., 46, D303, 10.1093/nar/gkx1030 · DOI · Paper page
  2. Saletore, 2012, The birth of the epitranscriptome: deciphering the function of RNA modifications, Genome Biol., 13, 175, 10.1186/gb-2012-13-10-175 · DOI · Paper page
  3. Mannion, 2014, The RNA-editing enzyme ADAR1 controls innate immune responses to RNA, Cell Rep., 9, 1482, 10.1016/j.celrep.2014.10.041 · DOI · Paper page
  4. O’Connell, 2015, The epitranscriptome and innate immunity, PLoS Genet., 11, 10.1371/journal.pgen.1005687 · DOI
  5. Eisenberg, 2018, A-to-I RNA editing – immune protector and transcriptome diversifier, Nat. Rev. Genet., 19, 473, 10.1038/s41576-018-0006-1 · DOI · Paper page
  6. Mannion, 2015, New insights into the biological role of mammalian ADARs; the RNA editing proteins, Biomolecules, 5, 2338, 10.3390/biom5042338 · DOI
  7. Matthews, 2016, Structures of human ADAR2 bound to dsRNA reveal base-flipping mechanism and basis for site selectivity, Nat. Struct. Mol. Biol., 23, 426, 10.1038/nsmb.3203 · DOI · Paper page
  8. Patterson, 1995, Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase, Mol. Cell. Biol., 15, 5376, 10.1128/MCB.15.10.5376 · DOI · Paper page
  9. Desterro, 2003, Dynamic association of RNA-editing enzymes with the nucleolus, J. Cell Sci., 116, 1805, 10.1242/jcs.00371 · DOI · Paper page
  10. Bazak, 2014, A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes, Genome Res., 24, 365, 10.1101/gr.164749.113 · DOI · Paper page
  11. Licht, 2019, Inosine induces context-dependent recoding and translational stalling, Nucleic Acids Res., 47, 3, 10.1093/nar/gky1163 · DOI · Paper page
  12. Tan, 2017, Dynamic landscape and regulation of RNA editing in mammals, Nature, 550, 249, 10.1038/nature24041 · DOI · Paper page
  13. Serra, 2004, Pronounced instability of tandem IU base pairs in RNA, Nucleic Acids Res., 32, 1824, 10.1093/nar/gkh501 · DOI
  14. Liddicoat, 2015, RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself, Science, 349, 1115, 10.1126/science.aac7049 · DOI · Paper page
  15. Pestal, 2015, Isoforms of RNA-editing enzyme ADAR1 independently control nucleic acid sensor MDA5-driven autoimmunity and multi-organ development, Immunity, 43, 933, 10.1016/j.immuni.2015.11.001 · DOI · Paper page
  16. Roost, 2015, Structure and thermodynamics of N6-methyladenosine in RNA: a spring-loaded base modification, J. Am. Chem. Soc., 137, 2107, 10.1021/ja513080v · DOI · Paper page
  17. Heale, 2009, Editing independent effects of ADARs on the miRNA/siRNA pathways, EMBO J., 28, 3145, 10.1038/emboj.2009.244 · DOI · Paper page
  18. Ota, 2013, ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing, Cell, 153, 575, 10.1016/j.cell.2013.03.024 · DOI · Paper page
  19. Ohman, 2000, In vitro analysis of the binding of ADAR2 to the pre-mRNA encoding the GluR-B R/G site, RNA, 6, 687, 10.1017/S1355838200000200 · DOI
  20. Kallman, 2003, ADAR2 A→I editing: site selectivity and editing efficiency are separate events, Nucleic Acids Res., 31, 4874, 10.1093/nar/gkg681 · DOI
  21. Ablasser, 2020, Regulation of cGAS- and RLR-mediated immunity to nucleic acids, Nat. Immunol., 21, 17, 10.1038/s41590-019-0556-1 · DOI · Paper page
  22. Wu, 2013, Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5, Cell, 152, 276, 10.1016/j.cell.2012.11.048 · DOI · Paper page
  23. Hartner, 2004, Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1, J. Biol. Chem., 279, 4894, 10.1074/jbc.M311347200 · DOI · Paper page
  24. Wang, 2015, ADAR1 prevents liver injury from inflammation and suppresses interferon production in hepatocytes, Am. J. Pathol., 185, 3224, 10.1016/j.ajpath.2015.08.002 · DOI
  25. Rawling, 2014, Parts, assembly and operation of the RIG-I family of motors, Curr. Opin. Struct. Biol., 25, 25, 10.1016/j.sbi.2013.11.011 · DOI
  26. Louber, 2015, Kinetic discrimination of self/non-self RNA by the ATPase activity of RIG-I and MDA5, BMC Biol., 13, 54, 10.1186/s12915-015-0166-9 · DOI
  27. Luo, 2011, Structural insights into RNA recognition by RIG-I, Cell, 147, 409, 10.1016/j.cell.2011.09.023 · DOI · Paper page
  28. Di Giorgio, 2020, Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2, Sci. Adv., 6, 10.1126/sciadv.abb5813 · DOI · Paper page
  29. Samuel, 2012, ADARs: viruses and innate immunity, Curr. Top. Microbiol. Immunol., 353, 163
  30. Yanai, 2020, ADAR2 is involved in self and nonself recognition of Borna disease virus genomic RNA in the nucleus, J. Virol., 94, e01513, 10.1128/JVI.01513-19 · DOI
  31. Li, 2016, Ubiquitin-dependent turnover of adenosine deaminase acting on RNA 1 (ADAR1) is required for efficient antiviral activity of type I Interferon, J. Biol. Chem., 291, 24974, 10.1074/jbc.M116.737098 · DOI
  32. Roth, 2019, Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity, Nat. Methods, 16, 1131, 10.1038/s41592-019-0610-9 · DOI · Paper page
  33. Bou-Nader, 2019, The search for a PKR code-differential regulation of protein kinase R activity by diverse RNA and protein regulators, RNA, 25, 539, 10.1261/rna.070169.118 · DOI
  34. Li, 2017, Ribonuclease L mediates the cell-lethal phenotype of double-stranded RNA editing enzyme ADAR1 deficiency in a human cell line, eLife, 6, 10.7554/eLife.25687 · DOI · Paper page
  35. Blango, 2016, Identification of the long, edited dsRNAome of LPS-stimulated immune cells, Genome Res., 26, 852, 10.1101/gr.203992.116 · DOI
  36. Li, 2018, ADAR1 attenuates allogeneic graft rejection by suppressing miR-21 biogenesis in macrophages and promoting M2 polarization, FASEB J., 32, 5162, 10.1096/fj.201701449R · DOI
  37. Solomon, 2017, RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure, Nat. Commun., 8, 1440, 10.1038/s41467-017-01458-8 · DOI
  38. Porath, 2017, Massive A-to-I RNA editing is common across the Metazoa and correlates with dsRNA abundance, Genome Biol., 18, 185, 10.1186/s13059-017-1315-y · DOI · Paper page
  39. Keegan, 2011, Functional conservation in human and Drosophila of Metazoan ADAR2 involved in RNA editing: loss of ADAR1 in insects, Nucleic Acids Res., 39, 7249, 10.1093/nar/gkr423 · DOI
  40. Khan, 2020, Membrane and synaptic defects leading to neurodegeneration in Adar mutant Drosophila are rescued by increased autophagy, BMC Biol., 18, 15, 10.1186/s12915-020-0747-0 · DOI
  41. Palladino, 2000, A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity, Cell, 102, 437, 10.1016/S0092-8674(00)00049-0 · DOI · Paper page
  42. Deddouche, 2008, The DExD/H-box helicase Dicer-2 mediates the induction of antiviral activity in Drosophila, Nat. Immunol., 9, 1425, 10.1038/ni.1664 · DOI · Paper page
  43. Deng, 2020, Adar RNA editing-dependent and -independent effects are required for brain and innate immune functions in Drosophila, Nat. Commun., 11, 1580, 10.1038/s41467-020-15435-1 · DOI
  44. Paradkar, 2014, Dicer-2-dependent activation of Culex Vago occurs via the TRAF-Rel2 signaling pathway, PLoS Negl. Trop. Dis., 8, 10.1371/journal.pntd.0002823 · DOI
  45. Scadden, 2001, RNAi is antagonized by A→I hyper-editing, EMBO Rep., 2, 1107, 10.1093/embo-reports/kve244 · DOI
  46. Reich, 2018, C. elegans ADARs antagonize silencing of cellular dsRNAs by the antiviral RNAi pathway, Genes Dev., 32, 271, 10.1101/gad.310672.117 · DOI
  47. van Eyk, 2019, Non-self mutation: double-stranded RNA elicits antiviral pathogenic response in a Drosophila model of expanded CAG repeat neurodegenerative diseases, Hum. Mol. Genet., 28, 3000, 10.1093/hmg/ddz096 · DOI
  48. Savva, 2013, RNA editing regulates transposon-mediated heterochromatic gene silencing, Nat. Commun., 4, 2745, 10.1038/ncomms3745 · DOI · Paper page
  49. Tsai, 2020, Epigenetic and epitranscriptomic regulation of viral replication, Nat. Rev. Microbiol., 18, 559, 10.1038/s41579-020-0382-3 · DOI · Paper page
  50. Miyamura, 2003, Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria, Am. J. Hum. Genet., 73, 693, 10.1086/378209 · DOI · Paper page
  51. Wang, 2019, Seven novel mutations of ADAR in multi-ethnic pedigrees with dyschromatosis symmetrica hereditaria in China, Mol. Genet. Genomic Med., 7, 10.1002/mgg3.905 · DOI
  52. Stenson, 2017, The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies, Hum. Genet., 136, 665, 10.1007/s00439-017-1779-6 · DOI · Paper page
  53. Zhang, 2013, The adenosine deaminase acting on RNA 1 p150 isoform is involved in the pathogenesis of dyschromatosis symmetrica hereditaria, Br. J. Dermatol., 169, 637, 10.1111/bjd.12401 · DOI
  54. Suganuma, 2020, Pathogenesis of a variant in the 5′ untranslated region of ADAR1 in dyschromatosis symmetrica hereditaria, Pigment Cell Melanoma Res., 33, 591, 10.1111/pcmr.12863 · DOI
  55. Gacem, 2020, ADAR1 mediated regulation of neural crest derived melanocytes and Schwann cell development, Nat. Commun., 11, 198, 10.1038/s41467-019-14090-5 · DOI
  56. Hayashi, 2013, Dyschromatosis symmetrica hereditaria, J. Dermatol., 40, 336, 10.1111/j.1346-8138.2012.01661.x · DOI
  57. Crow, 2014, Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia, Neuropediatrics, 45, 386, 10.1055/s-0034-1389161 · DOI
  58. Livingston, 2014, A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1, J. Med. Genet., 51, 76, 10.1136/jmedgenet-2013-102038 · DOI · Paper page
  59. Crow, 2020, Cardiac valve involvement in ADAR-related type I interferonopathy, J. Med. Genet., 57, 475, 10.1136/jmedgenet-2019-106457 · DOI
  60. Schmelzer, 2018, Variable clinical phenotype in two siblings with Aicardi-Goutieres syndrome type 6 and a novel mutation in the ADAR gene, Eur. J. Paediatr. Neurol., 22, 186, 10.1016/j.ejpn.2017.11.003 · DOI
  61. Kondo, 2008, Dyschromatosis symmetrica hereditaria associated with neurological disorders, J. Dermatol., 35, 662, 10.1111/j.1346-8138.2008.00540.x · DOI
  62. Kono, 2018, Bilateral striatal necrosis and dyschromatosis symmetrica hereditaria: A-I editing efficiency of ADAR1 mutants and phenotype expression, Br. J. Dermatol., 179, 509
  63. Kono, 2016, Dyschromatosis symmetrica hereditaria and Aicardi-Goutieres syndrome 6 are phenotypic variants caused by ADAR1 mutations, J. Invest. Dermatol., 136, 875, 10.1016/j.jid.2015.12.034 · DOI
  64. Comabella, 2009, Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis, Arch. Neurol., 66, 972, 10.1001/archneurol.2009.150 · DOI
  65. Hornbeck, 2015, PhosphoSitePlus, 2014: mutations, PTMs and recalibrations, Nucleic Acids Res., 43, D512, 10.1093/nar/gku1267 · DOI · Paper page
  66. Fumagalli, 2015, Principles governing A-to-I RNA editing in the breast cancer transcriptome, Cell Rep., 13, 277, 10.1016/j.celrep.2015.09.032 · DOI · Paper page
  67. Paz-Yaacov, 2015, Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors, Cell Rep., 13, 267, 10.1016/j.celrep.2015.08.080 · DOI · Paper page
  68. Liu, 2019, Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss, Nat. Med., 25, 95, 10.1038/s41591-018-0302-5 · DOI · Paper page
  69. Gannon, 2018, Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells, Nat. Commun., 9, 5450, 10.1038/s41467-018-07824-4 · DOI · Paper page
  70. Jiang, 2020, Progress and challenges in precise treatment of tumors with PD-1/PD-L1 blockade, Front. Immunol., 11, 339, 10.3389/fimmu.2020.00339 · DOI
  71. Xu, 2018, ADAR1 editing and its role in cancer, Genes (Basel), 10, 12, 10.3390/genes10010012 · DOI
  72. Rice, 2013, Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study, Lancet Neurol., 12, 1159, 10.1016/S1474-4422(13)70258-8 · DOI · Paper page
  73. Crow, 2015, Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1, Am. J. Med. Genet. A, 167A, 296, 10.1002/ajmg.a.36887 · DOI · Paper page
  74. Kono, 2019, Dyschromatosis symmetrica hereditaria and reticulate acropigmentation of Kitamura: an update, J. Dermatol. Sci., 93, 75, 10.1016/j.jdermsci.2019.01.004 · DOI
  75. Haralambieva, 2010, 2′-5′-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine, Hum. Immunol., 71, 383, 10.1016/j.humimm.2010.01.004 · DOI
  76. Wu, 2012, Polymorphisms in ADAR1 gene affect response to interferon alpha based therapy for chronic hepatitis B in Han Chinese, Antivir. Res., 94, 272, 10.1016/j.antiviral.2012.03.004 · doi:10.1016/j.antiviral.2012.03.004
  77. Wu, 2014, SLEEPLESS is a bifunctional regulator of excitability and cholinergic synaptic transmission, Curr. Biol., 24, 621, 10.1016/j.cub.2014.02.026 · DOI · Paper page
  78. Haralambieva, 2011, Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine, Vaccine, 29, 8988, 10.1016/j.vaccine.2011.09.043 · DOI
  79. Kennedy, 2014, Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination, Hum. Genet., 133, 1407, 10.1007/s00439-014-1471-z · DOI
  80. Ovsyannikova, 2015, Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children, Immunogenetics, 67, 547, 10.1007/s00251-015-0864-z · DOI
  81. Medrano, 2017, ADAR1 polymorphisms are related to severity of liver fibrosis in HIV/HCV-coinfected patients, Sci. Rep., 7, 12918, 10.1038/s41598-017-12885-4 · DOI
  82. Permuth, 2016, Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration, Oncotarget, 7, 72381, 10.18632/oncotarget.10546 · DOI
  83. Hwang, 2006, Genetic predisposition of responsiveness to therapy for chronic hepatitis C, Pharmacogenomics, 7, 697, 10.2217/14622416.7.5.697 · DOI
  84. Welzel, 2009, Variants in interferon-alpha pathway genes and response to pegylated interferon-alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial, Hepatology, 49, 1847, 10.1002/hep.22877 · DOI
  85. El-Derany, 2016, Integrative role of vitamin D related and interleukin-28B genes polymorphism in predicting treatment outcomes of chronic hepatitis C, BMC Gastroenterol., 16, 19, 10.1186/s12876-016-0440-5 · DOI
  86. Pankratz, 2010, Associations between SNPs in candidate immune-relevant genes and rubella antibody levels: a multigenic assessment, BMC Immunol., 11, 48, 10.1186/1471-2172-11-48 · DOI

Cited by

See all 148

Metadata

Authors
Quin, J., Sedmík, J., Vukić, D., Khan, A., Keegan, L. P., & O’Connell, M. A.
Venue
Trends in Biochemical Sciences
Publisher
Elsevier BV
Published
2021-09
Volume
46
Issue
9
Pages
758-771
ISSN
0968-0004
Cited by
148
References
10
Language
en
Licence
Funders
  • GAČR (20-11101S)
  • Ministerstvo Školství, Mládeže a Tělovýchovy (GA\u010CR 19-16963S, LTC18052)
  • European Commission (867470)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ADAR RNA Modifications, the Epitranscriptome and Innate Immunity. https://app.cochat.ai/papers/10.1016/j.tibs.2021.02.002
The paper
Quin, J., Sedmík, J., Vukić, D., Khan, A., Keegan, L. P., & O’Connell, M. A. (2021). ADAR RNA Modifications, the Epitranscriptome and Innate Immunity. Trends in Biochemical Sciences. https://doi.org/10.1016/j.tibs.2021.02.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.